1. Demandante CG, Troyer DA, Miles TP. Multiple primary malignant neoplasms: case report and a comprehensive review of the literature. Am J Clin Oncol. 2003; 26:79–83.
2. Lee JH, Bae JS, Ryu KW, Lee JS, Park SR, Kim CG, et al. Gastric cancer patients at high-risk of having synchronous cancer. World J Gastroenterol. 2006; 12:2588–2592.
3. Warren S, Gates O. Multiple primary maligant tumors: a survey of the literature and a statistical study. Am J Cancer. 1932; 16:1358–1414.
4. Little SG, Rice TW, Bybel B, Mason DP, Murthy SC, Falk GW, et al. Is FDG-PET indicated for superficial esophageal cancer? Eur J Cardiothorac Surg. 2007; 31:791–796.
5. Yasuda S, Ide M, Fujii H, Nakahara T, Mochizuki Y, Takahashi W, et al. Application of positron emission tomograp hy imag ing to cancer screening. Br J Cancer. 2000; 83:1607–1611.
6. Hamada M, Naomoto Y, Fujiwara T, Kamikawa Y, Tanaka N. Suppressed apoptotic induction in esophageal squamous cell carcinomas expressing extensive p53 protein. Jpn J Clin Oncol. 1996; 26:398–404.
7. Bae JS, Lee JH, Ryu KW, Kim YW, Bae JM. Characteristics of synchronous cancers in gastric cancer patients. Cancer Res Treat. 2006; 38:25–29.
8. Cho I, An JY, Kwon IG, Choi YY, Cheong JH, Hyung WJ, et al. Risk factors for dou ble primary malignancies and their clin ical implications in patients with spo radic gastric cancer. Eur J Surg Oncol. 2014; 40:338–344.
9. Yoshino K, Asanuma F, Hanatani Y, Otani Y, Kumai K, Ishibiki K. Multiple primary cancers in the stomach and another organ: frequency and the effects on prognosis. Jpn J Clin Oncol. 1985; 15:Suppl 1. 183–190.